KTESCA: Peripheral Catheter Pressure Ulcer Prevention in Pediatry : Use of Compresses Versus Standard Care

Sponsor
Centre Hospitalier Departemental Vendee (Other)
Overall Status
Recruiting
CT.gov ID
NCT04540822
Collaborator
(none)
360
1
2
24.2
14.9

Study Details

Study Description

Brief Summary

Peripheral venous catheterisation is a multi-daily practice in a paediatric ward.

In our pediatrics department, nurses have observed for several years now the appearance of pressure sore-like skin lesions at the junction of the peripheral venous catheter with the extension tube. A ward habit has spontaneously developed of applying a compress under this junction. The objective is to minimize physical or emotional aggression as well as pain. Pain that is denied or not identified and not relieved is memorized by the child, which can have consequences on the perception of pain and the subsequent acceptance of care.

To date, through their reading and research, investigators have been able to find articles mentioning the risks of pressure ulcers in children related to medical devices. However, few elements are developed concerning catheter-related pressure ulcers, especially on this specific technique for preventing injuries at the catheter-extension tube junction. Investigators have not found any recommendations on this subject.

Thus, the aim of this study is to compare two peripheral venous catheter fixation devices, with compress and without compress, and to analyse the frequency of pressure ulcer occurrence and the intensity of this lesion.

Condition or Disease Intervention/Treatment Phase
  • Other: peripheral venous catheter with compress under the catheter-extension tube junction
  • Other: peripheral venous catheter without compress under the catheter-extension tube junction
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
360 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
The childcare assistant in charge of primary outcome assessment should not having taken care of the child before. In addition, the catheter-extension tube junction, with or without compress,will be secured by placing a crepe bandage. The nurse will call him to assess the primary outcome after the catheter ( and compress and crepe bandage) will have been removed.
Primary Purpose:
Prevention
Official Title:
Peripheral Catheter Pressure Ulcer Prevention in Pediatry : Use of Compresses Versus Standard Care"
Actual Study Start Date :
Sep 22, 2020
Anticipated Primary Completion Date :
Sep 29, 2022
Anticipated Study Completion Date :
Sep 29, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: peripheral venous catheter with compress

Insertion of a peripheral venous catheter with a compress inserted below the catheter-extension tube junction

Other: peripheral venous catheter with compress under the catheter-extension tube junction
Placement of a BD Insyte® type catheter of 20 to 24 Gauge calibre on a peripheral vein located in the crease of the elbow or top of the hand or scalp or top of the foot. The catheter is placed while respecting the detersion and disinfection of the skin with the appropriate products and according to the procedure in force in the department. Once the venous return has been checked, a 10 cm extension with a BECTON-DIC® 3-way valve will be connected, which is previously purged with 0.9% Sodium Chloride. Under the catheter-extension tube junction will be inserted a sterile non-woven compress, cut sterilely (3.5x1.5 cm). The assembly will be held in place by a transparent sterile semi-permeable adhesive dressing such as Tegaderm® (5x7 cm). This area will be secured by placing a crepe bandage (crepe bandage 4 m x7 cm).

Active Comparator: peripheral venous catheter without compress

Insertion of a peripheral venous catheter without any compress inserted below the catheter-extension tube junction.

Other: peripheral venous catheter without compress under the catheter-extension tube junction
Placement of a BD Insyte® type catheter of 20 to 24 Gauge calibre on a peripheral vein located in the crease of the elbow or top of the hand or scalp or top of the foot. The catheter is placed while respecting the detersion and disinfection of the skin with the appropriate products and according to the procedure in force in the department. Once the venous return has been checked, a 10 cm extension with a BECTON-DIC® 3-way valve will be connected, which is previously purged with 0.9% Sodium Chloride. No compresses will be inserted under the catheter-extension tube junction.The assembly will be held in place by a transparent sterile semi-permeable adhesive dressing such as Tegaderm® (5x7 cm). This area will be secured by placing a crepe bandage (crepe bandage 4 m x7 cm).

Outcome Measures

Primary Outcome Measures

  1. Pressure ulcer of grade >=1 on the National Pressure Ulcer Advisory Panel (NPUAP) scale [at catheter removal]

    Appearance of a grade >=1 pressure ulcer on the NPUAP scale at the catheter extension junction. The assessment will be conducted blind by a child care assistant (CDA) from the department.

Secondary Outcome Measures

  1. Pressure ulcer intensity as measured by the NPUAP scale [at catheter removal]

    The NPUAP pressure ulcer rating scale translated in French by the National French Agency for accreditation and assessment of Health (ANAES) will be used. This scale evaluates pressure ulcers according to 4 stages graduated from 1 to 4. Stage 1 being the least severe.

  2. dwell time of peripheral venous catheters between the 2 groups [at catheter removal]

    Will be calculated from the time of catheter placement to the time of catheter removal.

  3. Presence of a nosocomial infection related to the peripheral venous catheter. [at catheter removal +48hours]

    Will be defined as a peripheral venous catheter culture > 10^3 Colony Forming Unit/ml, if the peripheral venous catheter is referred in culture on suspicion of infection and in the absence of antibiotic treatment. In the presence of antibiotic treatment, it will be defined by the presence of pus and/or regression of infectious signs within 48 hours after removal of the peripheral venous catheter.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 1 month to 18 years old, according to the criteria of the paediatrics department of the Departmental Hospital la Roche sur Yon .

  • Hospitalized in paediatrics ward or consultant in paediatric emergencies with a high probability of being hospitalized in paediatrics ward later.

  • With an indication for the insertion of a short peripheral venous catheter

  • Written agreement from the holder(s) of parental authority

Exclusion Criteria:
  • Children with dermatological affections prior to inclusion and at the puncture site (atopic dermatitis, skin infection, skin wound, chickenpox, epidermolysis bullosa)

  • Allergy to fixation devices

  • Known immune deficient child

  • Refusal of the patient or of the holders of parental authority to participate

  • Life-saving emergency care

  • Patient already included in the study

  • Patient without social security coverage

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHD Vendee La roche sur yon France 85000

Sponsors and Collaborators

  • Centre Hospitalier Departemental Vendee

Investigators

  • Study Director: stephanie Chaillot, CHD VENDEE

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Departemental Vendee
ClinicalTrials.gov Identifier:
NCT04540822
Other Study ID Numbers:
  • CHD194-19
First Posted:
Sep 7, 2020
Last Update Posted:
Mar 14, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Departemental Vendee
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2022